Literature DB >> 33627175

Simvastatin impairs hippocampal synaptic plasticity and cognitive function in mice.

Yujun Guo1, Guichang Zou1, Keke Qi2, Jin Jin1, Lei Yao1, Yang Pan2, Wei Xiong3,4,5.   

Abstract

Lipophilic statins which are blood brain barrier (BBB) permeable are speculated to affect the cholesterol synthesis and neural functions in the central nervous system. However, whether these statins can affect cholesterol levels and synaptic plasticity in hippocampus and the in vivo consequence remain unclear. Here, we report that long-term subcutaneous treatments of simvastatin significantly impair mouse hippocampal synaptic plasticity, reflected by the attenuated long-term potentiation of field excitatory postsynaptic potentials. The simvastatin administration causes a deficiency in recognition and spatial memory but fails to affect motor ability and anxiety behaviors in the mice. Mass spectrometry imaging indicates a significant decrease in cholesterol intensity in hippocampus of the mice receiving chronic simvastatin treatments. Such effects of simvastatin are transient because drug discontinuation can restore the hippocampal cholesterol level and synaptic plasticity and the memory function. These findings may provide further clues to elucidate the mechanisms of neurological side effects, especially the brain cognitive function impairment, caused by long-term usage of BBB-permeable statins.

Entities:  

Keywords:  Cholesterol; Cognition; Hippocampus; Mass spectrometry imaging; Simvastatin

Year:  2021        PMID: 33627175     DOI: 10.1186/s13041-021-00758-x

Source DB:  PubMed          Journal:  Mol Brain        ISSN: 1756-6606            Impact factor:   4.041


  43 in total

1.  Structural mechanism for statin inhibition of HMG-CoA reductase.

Authors:  E S Istvan; J Deisenhofer
Journal:  Science       Date:  2001-05-11       Impact factor: 47.728

2.  Statin-related cognitive impairment in the real world: you'll live longer, but you might not like it.

Authors:  Jonathan McDonagh
Journal:  JAMA Intern Med       Date:  2014-12       Impact factor: 21.873

3.  Brain cholesterol synthesis in mice is affected by high dose of simvastatin but not of pravastatin.

Authors:  Karin M Thelen; Katharina M Rentsch; Ursula Gutteck; Maura Heverin; Maria Olin; Ulla Andersson; Arnold von Eckardstein; Ingemar Björkhem; Dieter Lütjohann
Journal:  J Pharmacol Exp Ther       Date:  2005-11-10       Impact factor: 4.030

4.  Statins for Primary Prevention of Cardiovascular Disease.

Authors:  Giuseppe Lippi; Mario Plebani
Journal:  Trends Pharmacol Sci       Date:  2016-12-22       Impact factor: 14.819

Review 5.  Statin Toxicity.

Authors:  Natalie C Ward; Gerald F Watts; Robert H Eckel
Journal:  Circ Res       Date:  2019-01-18       Impact factor: 17.367

Review 6.  Lovastatin and beyond: the history of the HMG-CoA reductase inhibitors.

Authors:  Jonathan A Tobert
Journal:  Nat Rev Drug Discov       Date:  2003-07       Impact factor: 84.694

7.  Cognitive impairment associated with atorvastatin and simvastatin.

Authors:  Deborah S King; Amanda J Wilburn; Marion R Wofford; T Kristopher Harrell; Brent J Lindley; Daniel W Jones
Journal:  Pharmacotherapy       Date:  2003-12       Impact factor: 4.705

Review 8.  A historical perspective on the discovery of statins.

Authors:  Akira Endo
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2010       Impact factor: 3.493

Review 9.  Cholesterol metabolism and homeostasis in the brain.

Authors:  Juan Zhang; Qiang Liu
Journal:  Protein Cell       Date:  2015-02-15       Impact factor: 14.870

Review 10.  Dysregulation of cholesterol balance in the brain: contribution to neurodegenerative diseases.

Authors:  Jean E Vance
Journal:  Dis Model Mech       Date:  2012-10-12       Impact factor: 5.758

View more
  5 in total

1.  Cranial irradiation induces cognitive decline associated with altered dendritic spine morphology in the young rat hippocampus.

Authors:  Xin Ding; Hai-Bo Zhang; Hui Qiu; Xin Wen; Long-Zhen Zhang
Journal:  Childs Nerv Syst       Date:  2022-08-13       Impact factor: 1.532

Review 2.  The role of DHCR24 in the pathogenesis of AD: re-cognition of the relationship between cholesterol and AD pathogenesis.

Authors:  Xiaojing Bai; Meiting Mai; Kai Yao; Mengqi Zhang; Yue Huang; Wenbin Zhang; Xiaorou Guo; Yixuan Xu; Ying Zhang; Atikam Qurban; Lijie Duan; Jimei Bu; Jianfeng Zhang; Junfeng Wu; Yongfei Zhao; Xiangshan Yuan; Hengbing Zu
Journal:  Acta Neuropathol Commun       Date:  2022-03-16       Impact factor: 7.578

Review 3.  Cardiovascular therapeutics: A new potential for anxiety treatment?

Authors:  Kristina Repova; Silvia Aziriova; Kristina Krajcirovicova; Fedor Simko
Journal:  Med Res Rev       Date:  2022-01-06       Impact factor: 12.388

Review 4.  Importance of Coagulation Factors as Critical Components of Premature Cardiovascular Disease in Familial Hypercholesterolemia.

Authors:  Uffe Ravnskov; Michel de Lorgeril; Malcolm Kendrick; David M Diamond
Journal:  Int J Mol Sci       Date:  2022-08-15       Impact factor: 6.208

Review 5.  Statins and cognition: Modifying factors and possible underlying mechanisms.

Authors:  Tahereh Jamshidnejad-Tosaramandani; Soheila Kashanian; Mohamed H Al-Sabri; Daniela Kročianová; Laura E Clemensson; Mélissa Gentreau; Helgi B Schiöth
Journal:  Front Aging Neurosci       Date:  2022-08-15       Impact factor: 5.702

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.